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Abstract 
Background: Visceral hypersensitivity (VH) is a common condition in many gastrointestinal disorders such as 
inflammatory bowel diseases (IBDs) in human and animals. Most studies often induce Crohn’s disease/colitis to 
investigate VH in small experimental animals. Although farm animals commonly suffer from IBDs, their VH has not 
been investigated so far. Because goats can suffer from Johne’s disease, a naturally occurring Crohn’s‑like disease, 
they may be suitable to be used for studying the mechanism underlying VH in common intestinal disorders of large 
animals. In the present study, 60 healthy goats of either sex were equally divided into a 2, 4, 6‑trinitrobenzenesulfonic 
acid (TNBS) group and saline group. A volume of 1.2 ml of TNBS‑ethanol solution (30 mg TNBS in 40 % ethanol) or 
an equal volume of isotonic saline was injected into the wall of the terminal ileum through laparotomy. The severity 
of the developing ileitis was determined according to macro‑ and microscopic pathologic scores and the levels of 
myeloperoxidase, interleukin‑1β, interleukin‑6 and tumor necrosis factor‑α, and VH was evaluated with visceromo‑
tor responses (VMR) to colorectal distension on days 3, 7, 14, 21 and 28. VMRs were assessed with a continuous ramp 
distention mode with 6 s for each pressure (20, 40, 60, 80 and 100 mmHg).
Results: Compared to the saline group, the TNBS‑treated goats showed apparent transmural pathological changes 
and a significant increase (P < 0.05) in macroscopic and microscopic change scores, and levels of myeloperoxidase, 
interleukin‑1β, interleukin‑6 and tumor necrosis factor‑α in the ileum, and VMR to colorectal distension. The goats 
exhibited apparent ileitis at days 3 to 21, and VH at days 7 to 28 following TNBS treatment.
Conclusion: This experiment successfully established a reproducible ileitis and VH with administration of TNBS‑eth‑
anol solution in the ileal wall of goats. This model is useful for studying the pathogenesis of the IBD and the mecha‑
nism underlying VH, and for evaluating the efficacy of new therapeutic regimens.
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Background
Inflammatory bowel diseases (IBDs) are a collection 
of chronic inflammatory disorders of the gastrointes-
tinal tract in human and animals. The major symptoms 
are visceral hypersensitivity (VH) (visceral pain, altered 
bowel movement, increased mucosal secretion) with 
weight loss, malnutrition, fever and lack of appetite [1, 2]. 
VH is one of the important symptoms in about 50–70 % 
of patients experiencing the initial onset of IBD.
Johne’s disease (JD), a kind of IBDs, is seen in cattle, 
sheep and goats and is caused by Mycobacterium avium 
subsp. paratubersulosis. Gross lesions of JD include 
intense reddening, mucosal granulomatous inflammation 
and wall thickening, especially in ileum [3]. This chronic 
intestinal disease occurs worldwide and causes mortal-
ity and productivity loss of ruminants [4, 5]. JD shares 
many similarities with human Crohn’s disease (CD) in 
terms of symptoms, location and pathological changes. 
The small intestine, especially the terminal ileum, is the 
primary location of both diseases [6, 7]. VH is an impor-
tant characteristic of IBD in humans, but VH in rumi-
nants is rarely reported. Studies have indicated that VH 
may result from a dysregulated mucosal immunologic 
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response to one or more antigens present in the enteric 
flora as well as a genetic predisposition to the develop-
ment of this response [8–11]. However, its underlying 
mechanisms are still unknown. Most studies have inves-
tigated VH utilizing colitis models; however, such mod-
els are not appropriate for studying the exact mechanism 
by which ileitis induces VH because its location, dura-
tion, microbiota and central regulating mechanism are 
different.
Different chemicals such as acetic acid, formalin, indo-
methacin, 2, 4, 6-trinitrobenzenesulfonic acid (TNBS), 
carrageenan and dextran sodium sulfate have been used 
to study IBD. Among these chemicals, TNBS is the most 
commonly used. Nowadays, TNBS in combination with 
ethanol has been used to induce ileitis or colitis in mice 
[12], rats [13], guinea pigs [14, 15] and pigs [16]. Sev-
eral studies reported that intracolonic administration of 
TNBS-ethanol solution can provoke VH in rats [17–19]. 
So far no VH model of farm animals has been reported.
In the present study, a TNBS-ethanol solution was 
injected into goat’s terminal ileum wall to induce ile-
itis and VH. The macroscopic and microscopic dam-
age scores, and levels of myeloperoxidase (MPO) and 
cytokines were detected for evaluating the severity of the 
induced inflammation. Visceromotor response (VMR) to 
colorectal distension (CRD) was used to assess VH.
Methods
Experimental animals
Goats were thoroughly examined to ascertain their health 
status. The animals were kept under the same nutritional 
and managemental conditions. They were dewormed 
and acclimatized to the environment for 1  week before 
the initiation of the study. The experiment was approved 
by the Institutional Animal Care and Use Committee 
of Huazhong Agricultural University, Wuhan, China 
(HZAUSH-2015-007), and performed with the guidelines 
of the Committee for Research and Ethical Issues of the 
International Association for the Study of Pain.
Determination of TNBS dosage for model experiment
Eighteen male goats (about 1-year-old) were randomly 
divided into 6 groups i.e. saline, 40  % ethanol, 30  mg 
TNBS (Sigma Aldrich company, USA) and TNBS-ethanol 
solutions (20, 30 or 40 mg in 40 % ethanol), with 3 goats 
each group. The goats were kept off feed for 12 h prior to 
the experiment to avoid anaesthesia-induced regurgita-
tion and other respiratory complications. Baseline cardi-
nal parameters like respiratory rate, pulse rate and body 
temperature were recorded. The animals were premedi-
cated with atropine (0.03 mg/kg, IM), etamsylate (0.02 g/
kg, IM) and xylazole (0.10  mg/kg, IM, North China 
Pharmaceutical Co., Ltd, Hubei, China). Goats were 
placed on the left lateral recumbency. After the trachea 
was intubated to avoid aspiration of ruminal contents, 
anaesthesia was induced via intravenous administration 
of ketamine HCl (0.5  mg/kg/min, Yao Pharma Co., Ltd, 
China). The anaesthetic depth was judged according to 
eyelid and corneal reflexes and painful response to the 
prickle of the abdominal skin and coronary hooves. A 
6-cm incision was performed on the right flank abdomen 
following aseptic surgical principle, and the distal part of 
the ileum was identified and exteriorized. Total 1.2 ml of 
saline, 40 % ethanol, 30 mg TNBS or TNBS-ethanol solu-
tions (20, 30 and 40 mg in 40 % ethanol) was injected into 
the ileal wall through five points, approximately 15  cm 
proximal to the ileocecal junction, with a 30-gauge nee-
dle. The intestine was then returned to the abdominal 
cavity. The abdominal wall and peritoneum were closed 
using standard procedure. The goats were monitored till 
recovered from anaesthesia. Tramadol hydrochloride 
(5 mg/kg, IM) was injected to relieve postoperative pain 
for 2  days. The wound was treated with 1  % povidone 
iodine solution daily until completely healed. The animals 
were resubjected to a similar laparotomy on day 7. The 
ileal mesentery arteries and veins supplying the injected 
region were ligated with 3-0 chromic catgut. Four intes-
tinal clamps were applied on both sides of the injected 
part to prevent content leakage. The 6 cm terminal ileum 
of each goat was excised 15 cm proximal to the ileocecal 
junction. The ileum segment was flushed with phosphate 
buffered saline, cut longitudinally and placed flatly on a 
clean drape sheet. After detection of the macroscopic 
changes, a 2  ×  2  cm tissue block was taken from the 
approximate part of the ileum segment opposite to the 
mesentery, and stored in 10  % formalin for histopatho-
logical examination. An expert surgical team performed 
enteric end-to-end anastomosis immediately after the 
removal of the partial ileal segment and closed the abdo-
men using standard methods. The goats received trama-
dol hydrochloride (5 mg/kg, IM) for 3 days and ampicillin 
(20  mg/kg, IM) for 5  days. After 2  week recovery, the 
animals were sent to goat farms. The ileitis severity was 
determined according to gross and microscopical lesions, 
and the dose of TNBS inducing moderate ileitis was cho-
sen for the model experiment.
Experimental setup
The experimental setup is illustrated in Fig.  1. Sixty 
goats (30 males and 30 females, about 1-year-old) were 
included. The animals were randomly divided into two 
equal groups receiving TNBS and isotonic saline, respec-
tively. The goats were anesthetized and laporatomized 
with the methods described above. The distal part of the 
ileum was exteriorized. For the TNBS group, 1.2  ml of 
TNBS-ethanol solution (30  mg TNBS in 40  % ethanol) 
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was injected into the ileal wall. In the saline group, the 
same volume of isotonic saline was injected in the same 
manner. Animals were weighed at days 0, 3, 7, 14, 21 and 
28 following surgery. Six animals were selected from 
each group at days 3, 7, 14, 21 and 28, respectively, for 
electromyography (EMG). After EMG, the goats imme-
diately underwent the same laparotomy. The ileum 
segment was handled as described above. After macro-
scopic changes were detected, a 2 ×  2  cm tissue block 
was taken from the approximate part of the segment 
opposite to the mesentery, and preserved in 10 % forma-
lin for histopathological examination. Another 2 × 2 cm 
tissue block was taken from the distal part opposite to 
the mesentery, weighed, frozen in liquid nitrogen and 
finally transferred to store in −80  °C for the measure-
ments of tumor necrosis factor-alpha (TNF-α), inter-
leukin-1 beta (IL-1β), interleukin-6 (IL-6) and MPO. 
Enteric end-to-end anastomosis and postoperative care 
were conducted as before.
Colorectal distension testing
VH was reflected by EMG. EMG was used to record 
VMR to CRD of goats at days 3, 7, 14, 21 and 28 after 
surgery as described previously [20]. Briefly, the goats 
were restrained to keep standing. A manual distension 
device was made using a T-connector connecting a bal-
loon, a vacuum pump and a sphygmomanometer. The 
polyethylene balloon (12 cm) was lubricated with paraffin 
and inserted into the distal colon 10  cm from the anus 
of goats 10  min before each VMR measurement. Two 
nickel-steel needles (0.45  mm in diameter and 5  cm in 
length) were inserted 2 cm apart directly into the exter-
nal oblique muscle at the center of the left abdomen as 
electrodes 5 min before each VMR. The electrodes were 
clamped with adjacent skin, respectively, and connected 
to an EMG recorder (Nanjing Medease Science and Tech-
nology Co., Ltd, China). EMG was amplified and filtered 
with a processing system MedLab-U/4C501H (Nanjing 
Medease Science and Technology Co., Ltd, China). The 
balloon was inflated with the pump. The pressure in the 
balloon was measured with the sphygmomanometer. In 
our pretest, goats showed VMR changes when distention 
pressure increased from 20 to 100  mmHg, and exhib-
ited stronger painful response when pressure reached to 
120  mmHg. Therefore, graded pressures (20, 40, 60, 80 
and 100 mmHg) were chosen for the model experiment. 
The balloon was inflated in a continuous ramp distension 
mode (20, 40, 60, 80 and 100 mmHg). EMG at each stage 
was recorded for 6  s. The procedure of balloon disten-
sion and EMG recordings was repeated every 5 min for 3 
times (Fig. 1). Average EMG values for 3 times were ana-
lyzed with MedLabV6.3 software (Nanjing Medease Sci-
ence and Technology Co., Ltd, China) and expressed as 
millivolt per second (mV/s).
Fig. 1 Illustration of the experimental design and electromyography protocol
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Macroscopic and microscopic observations
The macroscopic lesions were scored by two independ-
ent observers who were unaware of the treatments 
according to a scale of 0–10 (Table 1). The macroscopic 
scores were assessed according to adhesion of ileal sero-
sum to the intestinal loops, and mucosal pseudomem-
brane, hyperemia, ulceration, and wall thickening with 
a modification of the criteria described by Vadilla et  al. 
[21]. Samples were processed for the histological stud-
ies by routine techniques. Six series of 5 µm tissue sec-
tions were obtained. Three sections were stained with 
hematoxylin-eosin (HE). Another 3 were stained with 
0.5 % toluidine blue working solution for 3–5 min. Two 
pathologists were blindly assigned to examine and scored 
all sections according to crypt depth, inflammatory cells 
infiltration, submucosal thickness and blood vessel con-
gestion with a modification of the method described pre-
viously [21].
Measurement of cytokines and MPO
The ileal tissue was grinded in liquid nitrogen, and 
homogenized in 1 ml phosphate buffered solution, pH 7.2 
at 4 °C containing PMSF protein inhibitor. Homogenates 
were shaken at 60 Hz for 90 s, and the solution was cen-
trifuged at 5000×g at 4  °C for 15  min. The supernatant 
was harvested. The protein concentrations were deter-
mined using a Nano Drop Spectrophotometer (Thermo 
Fisher Scientific, Inc., USA). Concentrations of TNF-α, 
IL-1β, IL-6 and MPO were measured using ELISA kits 
(Neo Bioscience Inc. Shenzhen, China for cytokines; eBi-
oscience, Inc. USA for MPO) following the manufactur-
er’s instructions. Each sample was analyzed in triplicate 
and the values are presented as pg/mg.
Statistical analysis
Experimental data are presented as the mean ± SD. Sta-
tistical analyses were performed using SPSS version 18.0 
(SPSS Inc., Chicago, IL, USA). The statistical significant 
difference in macro- and micro-scopic scores between 
the groups was analyzed with the Mann–Whitney test. 
The statistical comparisons of other data were performed 
using independent t test. A difference was considered sig-
nificant if P value was less than 0.05.
Results
TNBS dose determination for ileitis
Gross or microscopic lesions were not observed in the 
ileum of goats of the saline group. The TNBS-alone 
treated ileums showed minute neutrophil infiltration and 
increased wall thickness. The severity of ileal inflamma-
tion increased with the increase of TNBS dose (0–40 mg) 
in 40 % ethanol. The gross or microscopic scores in 30 mg 
TNBS in 40 % ethanol were 5.67 ± 0.57 and 6.33 ± 0.58, 
respectively and significantly higher (P < 0.05) than that 
in the 20 mg TNBS in 40 % ethanol group (3.33 ± 0.57 
and 3.67  ±  0.58, respectively), but lower than that 
in 40  mg TNBS in 40  % ethanol (8.00  ±  1.00 and 
8.67  ±  1.15, respectively). Therefore, 30  mg TNBS in 
40 % ethanol induced a moderate ileitis and was chosen 
for further model experiments.
Effect of TNBS treatment on body weight
The saline-treated goats showed a decrease in body 
weight at day 3. The body weight of the TNBS-treated 
goats decreased at days 3 and 7. But both groups 
increased body weight at days 14 to 28. Compared with 
the saline group, body weight in the TNBS group was 
Table 1 Morphological criteria for the assessment of ileal damage
Macroscopic changes Scores Microscopic changes Scores
Adhesions None 0 Crypt depth Normal 0
Minimum 1 <50 % reduction 1
Involving several bowel loops 2 >50 % reduction 2
Mucosal hyperemia Normal 0 Inflammatory cells No infiltration 0
Mild 1 Few scattered cells 1
Moderate 2 Distributed but not dense 2
Severe 3 Dense 3
Ulcers None 0 Blood vessel congestion Normal 0
Ulceration <2 cm length 1 Mild 1
Two ulcers <2 cm 2 Moderate 2
More sites of ulceration or one >2 cm 3 Severe 3
Wall thickness Normal 0 Ulceration Normal 0
50 % increase 1 Moderate 1
100 % increase 2 Severe 2
Maximum scores 10 Maximum scores 10
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lower (P  =  0.028 and 0.021) at days 7 and 14. There 
was no difference (P  =  0.12 and 0.622) in body weight 
between two groups at days 21 and 28 (Fig. 2c).
Macroscopic and microscopic changes of the TNBS‑treated 
ileum
Gross lesions were not observed at days 3 to 21 after ileal 
saline injection. In the TNBS group, the ileal mucosa 
showed apparent congestion, hemorrhage, necrosis 
and wall thickness with widespread pseudo-membrane 
adhered to the mucosa at day 3, and light red color, spo-
radic adhered pseudo-membrane, localized necrosis 
and apparent wall thickening at day 7, and mild conges-
tion and wall thickening at day 14 (Fig. 2a). No apparent 
lesions were observed in the adjacent visceral organs and 
tissues such as large intestines, jejunum and mesentery. 
Macroscopic lesion scores in the TNBS-treated ileum 
at days 3, 7 and 14 were 8.43  ±  1.29, 5.54  ±  1.11 and 
2.90  ±  1.50, respectively and significantly more severe 
(P  <  0.05) than those in the saline group (2.45  ±  0.99, 
1.33 ± 0.98 and 0.95 ± 0.79, respectively). However, there 
was no difference (P > 0.05) in macroscopic lesion scores 
between the saline and TNBS treatments at days 21 and 
28 (Fig. 2b).
In the saline-treated goats, there were minute infil-
trated inflammatory cells at day 3, but no inflammatory 
changes at days 7 to 28. In the TNBS group, the ileal 
wall showed apparent inflammatory cells infiltration and 
ulceration at day 3, extensive inflammatory cells infil-
tration, and apparent submucosal and muscular layer 
ulceration and blood vessel congestion at day 7, extensive 
inflammatory cells infiltration and granuloma at day 14, 
and moderate inflammatory cells infiltration and granu-
loma in the submucosa and muscular layer at day 21. 
Microscopic lesions were not observed in ileum at day 28 
after TNBS treatment. Microscopic lesion scores in the 
TNBS group at days 3, 7, 14, and 21 were 8.78 ±  0.78, 
7.11 ±  0.86, 5.41 ±  1.77 and 3.25 ±  0.52 and therefore 
significantly more severe  (P  <  0.05) than those of the 
saline group (2.17 ±  0.75, 1.16 ±  0.75, 0.88 ±  0.61 and 
0.5  ±  0.54, respectively). However, there was no differ-
ence (P > 0.05) in microscopic lesion scores between the 
two groups at day 28 (Fig. 3). The number of mast cells 
in the ileum of the TNBS-group at days 3 and 7 were 
Fig. 2 Morphologic changes (a), macroscopic scores (b) and body weight changes (c) of the TNBS‑treated ileum in goats. TNBS group showed 
severe inflammation, ulceration and wall thickening at day 3, considerable damage in ileum at day 7, severity of these damages were decreased 
at day 14. The values are mean ± SD, n = 6. *P < 0.05 and **P < 0.01 show significant difference compared with the control
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58.63  ±  9.30 and 50.62  ±  11.48 per mm2, compared 
to 24.33  ±  8.27 and 24.51  ±  5.51 in the saline group 
(P  <  0.01). However, there was no difference (P  >  0.05) 
in mast cell counts between the saline and TNBS treat-
ments at days 14 to 28 (Fig. 4). 
Concentrations of MPO and cytokines in the ileal tissue
In the saline group, changes were not observed in levels 
of MPO, TNF-α, IL-1β or IL-6 throughout the experi-
ment. The concentrations of MPO in the TNBS-treated 
ileum were 2089.03  ±  435.30  pg/mg at day 3 and 
1406.27 ± 264.53 pg/mg at day 7, i.e. significantly higher 
than in the saline group (P < 0.01) (977.65 ± 168.47 and 
913.47  ±  214.57  pg/mg, respectively). The MPO con-
centrations between two groups at days 14 to 28 did 
not differ (P > 0.05) (Fig. 5a). Compared with the saline 
group, concentrations of TNF-α, IL-1β and IL-6 in the 
TNBS group increased (P < 0.05) by 208.67, 364.72 and 
330.15 % at day 3, and by 126.69, 168.71 and 209.60 % at 
day 7. The concentrations of IL-1β and IL-6 in the TNBS 
Fig. 3 Microscopic lesions and microscopic lesion scores of the TNBS‑treated ileum in goats. No significant inflammation in saline group, an 
extensive disruption of mucosal and submucosal layers, and inflammatory cell infiltration at day 3, ulceration of submucosal and muscular layers 
and inflammatory cell infiltration at day 7, Extensive inflammatory cells infiltration and granulomas at day 14, moderate infiltration of inflammatory 
cells and granulomas at 21 day after TNBS administration. The values are mean ± SD, n = 6. *P < 0.05 and **P < 0.01 show significant difference 
compared with the control
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group increased (P < 0.05) by 140.22 and 143.93 % at day 
14, respectively.
There were no differences (P > 0.05) in the concentra-
tions of TNF-α at days 14 to 28 and IL-1β and IL-6 at 
days 21 to 28 between two groups (Fig. 5b–d).
Visceromotor response
Graded balloon distension (20, 40, 60, 80 and 100 mmHg) 
in colorectum resulted in VMR at days 7, 14, 21 and 
28. The goats showed signs such as restlessness, rapid 
breathing, guarding, tail wagging, lips curling, head back 
to the abdomen and posture change when balloon disten-
sion was applied. There was no difference (P  >  0.05) in 
VMR between the saline group and TNBS group at day 3. 
VMRs in the TNBS-treated goats were higher (P < 0.05) 
than those in the saline control in a pressure-dependent 
manner at days 7 to 28 except for that with 40  mmHg 
at day 28. Compared with the saline group, VMR in the 
TNBS group increased (P  <  0.05) with 40, 60, 80 and 
100  mmHg at day 7. VMR in the TNBS-treated goats 
increased (P < 0.05) with 40 mmHg, and reached greatest 
(P < 0.01) with 60, 80 and 100 mmHg at days 14 and 21. 
At day 28, VMR in the TNBS group increased (P < 0.05) 
with 60 and 80 mmHg, and further increased (P < 0.01) 
with 100 mmHg (Fig. 6).
Discussion
Rectal instillation of TNBS-ethanol solution is an estab-
lished model that is used to examine the pathogenesis of 
acute and chronic colitis, and to determine the mecha-
nisms and efficacy of therapies. Some researchers have 
administered TNBS to induce ileitis. It seems that the 
inflammatory response of small intestine to TNBS is dif-
ferent from the well-characterized response of the colon. 
Most studies have shown that TNBS-induced ileitis 
lasts several days whereas the colitis persists for several 
weeks after TNBS administration. The administration 
and doses of TNBS differ between studies; the methodol-
ogy is inconsistent, and no standardized protocol exists. 
Moreels et  al. [22] injected 85  mg/kg body weight of 
TNBS in 40 % ethanol into rat’s ileum and found a marked 
inflammatory reaction occurred at 36 h and lasted up to 
Fig. 4 Mast cells in the ileal mucosa and mast cells count of the TNBS‑treated ileum in goats. Mast cells were stained with 0.5 % toluidine blue 
(×200). Mast cells in saline group and in TNBS group at day 7 after treatments. The values are mean ± SD, n = 6 **P < 0.01 shows significant differ‑
ence compared with the control
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7 days according to MPO concentration and macroscopic 
and microscopic pathologic changes. O’Hara et  al. [23] 
injected 60  mg/kg body weight of TNBS in 30  % etha-
nol into the ileum of guinea pigs and observed a severe 
inflammation at day 3. Nurgali et al. [24] translumenally 
administered 30 mg/kg body weight TNBS in 30 % etha-
nol in guinea pigs and observed the clinically as well as 
histologically inflammatory evidences up to 7 days. Mer-
ritt et  al. [16] injected TNBS-ethanol solutions (0.5–1 g 
TNBS in 33–75  % ethanol) into the ileal lumen of pigs, 
and induced ileitis up to 7 days. These studies showed a 
transient ileitis induced by TNBS in these animals.
Most researchers have administered TNBS-ethanol 
solution (30 to 150 mg/kg body weight or 10 to 40 mg/
rat of TNBS in 30 to 50  % ethanol) into the intestinal 
lumen to induce colitis or ileitis in rats. Studied showed 
that 50  % ethanol or 30  mg TNBS alone induced mild 
colitis for <7  days while 10 to 30  mg TNBS in combi-
nation with ethanol (30 or 50  %) caused mild to severe 
colitis for over 21 days in rats [25, 26]. We injected differ-
ent TNBS-ethanol solutions (20, 30 and 40 mg TNBS in 
40 % ethanol) into the ileal wall of goats, provoked mild 
to severe ileitis. It is believed that TNBS and ethanol act 
in concert on the intestinal tissue. TNBS as a hapten can 
bind intestinal tissue proteins, induce inflammatory and 
immune responses, and result in VH [17, 27]. Ethanol 
induces acute inflammation and may contribute to TNBS 
diffusion. The action of TNBS-ethanol solution in the 
lumen of the intestines was influenced by many factors. 
Intestine emptying, mucus secretion and peristalsis may 
reduce the contact time of TNBS with the ileal mucosa, 
influence severity and duration of inflammation [16]. To 
avoid these influences, Czaja et al. [28] injected 4 % para-
formaldehyde into the multiple sites of the ileal wall of 
pigs and found that apparent transient ileitis occurred at 
day 3. So far ileitis induced by TNBS injection into the 
ileal wall has not been reported. Our study showed that 
administration of TNBS-ethanol solution (30  mg TNBS 
in 40 % ethanol) in the ileal wall caused moderate ileitis 
of each goat, characterized by weight loss, diarrhea, and 
histopathologically apparent changes including exten-
sive congestion, hemorrhage, mucosal necrosis, granu-
lomas, diffuse infiltrated neutrophils and lymphocytes in 
lamina propia, and thickened wall. These symptoms and 
pathological changes are similar to JD. According to mac-
roscopic and microscopic changes, the TNBS-induced 
ileitis in our experiment occurred at day 3, persisted till 
day 21 and disappeared at day 28.
a b
c d
Fig. 5 Measurement of MPO (a) and cytokines level like TNF‑α (b), IL‑1β (c) and IL‑6 (d), and in ileum after TNBS administration (mean ± SD, n = 6). 
*P < 0.05 and **P < 0.01 show significant difference compared with the control
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JD usually occurs in ruminants, and its transmu-
ral lesions include thickened wall and granulomas in 
the small intestine, which is similar to human CD [3]. 
According to the CD study, microbial invasion and acti-
vation of immune response may have an important role 
in the development of these lesions [29]. Epidemiology 
suggests some relationship between gut flora and inflam-
matory granulomas. Ruminants have more bacteria in the 
cecum than other omnivorous and carnivorous animals. 
The granuloma development in the present study showed 
that enteric immune system was activated by a number 
of microorganisms existing in the ileum and proliferating 
Fig. 6 Representative electromyography (EMG) traces at day 14 and visceromotor responses (VMR) to colorectal distension (mean ± SD, n = 6) at 
days 3, 7, 14, 21 and 28 after treatments. *P < 0.05 and **P < 0.01 show significant difference compared with the control
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under the pathological condition or their retrograding 
from the cecum.
Abdominal pain and discomfort are amongst the most 
frustrating symptoms for patients suffering from IBD. 
They not only occur during acute flares of inflammation 
but also do during remission [30, 31]. Adam et  al. [17] 
intracolonally administered TNBS in Lewis rats, and 
found VH occurred at day 3, disappeared at day 14, and 
reappeared at day 28 to 42 after TNBS administration. 
Zhou et al. [18] used 20 mg TNBS in 50 % ethanol in the 
colon of Sprague-Dawley rats, observed VH at days 2 to 
28. Feng et al. [32] injected TNBS into the colon lumen 
of mice, and observed VH at days 7 to 14. Shah et al. [20] 
injected TNBS into the ileal lumen of Sprague-Dawley 
rats, observed ileitis at day 3, followed by VH at days 7 to 
21. The discrepancies in onset time and duration of VH 
above may be due to different inflammation locations and 
species. We injected TNBS into the ileal wall of goats, 
observed a significant VH at days 7 to 28, which is similar 
to the results of Shah et al. [20]. Because our experiment 
stopped at day 28, how long the VH lasted needs to be 
further confirmed.
A single visceral afferent fiber can span over ten spi-
nal cord segments, send terminal branches throughout 
the superficial and deep dorsal horn, as well as project 
to the contralateral dorsal horn [33, 34]. Studies showed 
that VH from the colorectum is mediated via both thora-
columbar and lumbosacral spinal afferent pathways 
whereas VH from terminal ileum is mainly mediated via 
thoracolumbar spinal afferent pathways [35–37]. Because 
there is a viscero-visceral convergence of nociceptive 
impulses from small and large intestines on the spinal 
neurons, CRD can be used as a nociceptive stimulator for 
ileum hypersensitivity. EMG is the most commonly used 
technique to quantify the abdominal muscle contractions 
in response to graded CRD.
Studies showed that in biopsies obtained from patients 
with IBDs, the number of mast cells was increased [38]. 
Shah et al. [20] found increased mast cells at day 3, fol-
lowed by VH at day 7 after administration of TNBS into 
the ileal lumen of rats. Our study showed that admin-
istration of TNBS in the ileal wall induced increased 
mast cells at days 3 to 7, and VH at days 7 to 28 in goats, 
which is in consistency with the results of Shah et  al. 
[20]. Ohashi et al. [39] injected TNBS into the proximal 
colon of wild rats and mast cell knockout rats, and found 
that TNBS induced VH in the wild rats, but not in the 
mast cell deficient rats. Studies have showed that TNBS-
induced VH can be suppressed by an oral treatment with 
a mast cell stabilizer, doxantrazole, in a dose-dependent 
manner [40]. The activated mast cells are demonstrated 
to release inflammatory mediators (cytokines, protease 
etc.), thereby activate protease-activated receptor-2 
(PAR-2). The activation of PAR-2 leads to sensitizing 
transient receptor potential vanilloid subtype-1 recep-
tors and to trigger the release of substance-P (SP) and 
calcitonin gene-related peptide (CGRP), which ultimately 
elicits neurogenic inflammation and hypersensitivity [17, 
41, 42]. These studies suggest an important role of mast 
cells in the initiation and development of VH.
Although the causes of VH is unknown, microbial 
activation of immune system and induction of pro-
inflammatory cytokines such as IL-6, TNF-α and IL-1β 
seem to be critical in genetically predisposed individu-
als. Adam et al. [11] reported that VH occurred in Lewis 
rats with increased IL-6 level, but not in Fisher rats 
without increased IL-6 level. Deletion of the regulatory 
sequence consisting of adenosine-uracil multimers in the 
3’untranslated region of cytokine-encoding transcripts in 
mice results in increased transcription and expression of 
TNF-α upon cell activation. These mice spontaneously 
develop a granulomatous CD-like disorder and an arthri-
tis-like inflammation [43]. It is demonstrated that TNF-α 
triggers the subsequent release of IL-1β, which can pro-
duce hypersensitivity.
Conclusions
Injection of 30  mg TNBS in 40  % ethanol into the ter-
minal ileal wall of goats induced apparent inflammation 
and transmural lesions, which are morphologically very 
similar to JD and human CD. VMR results showed that 
VH occurred at day 7 after TNBS injection and lasted 
up to day 28. This experiment successfully constructed a 
more economic (compared with TNBS injection into the 
intestinal lumen) and reproducible ileitis and VH, which 
is useful for studying the pathogenesis of ruminant’s and 
human IBDs, and the mechanism underlying VH, and for 
evaluating the efficacy of new therapeutic regimens.
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